 | |
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 2005 |
| Headquarters | Boston, United States |
Key people | Christopher Viehbacher (Chairman) Daphne Zohar (CEO) |
| Products | Medicines |
| Revenue |  $3.3 million (2023)[1] |
 $(146.2) million (2023)[1] | |
| $(66.6) million (2023)[1] | |
| Website | puretechhealth |
PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
YouTube Encyclopedic
-
1/3Views:14 52422 4246 072
-
Amplifying Scientific Innovation® Video Podcast with Daphne Zohar, Founder & CEO, PureTech Health
-
【ICF2015】伊藤穰一 - デザインの再定義「デザインは自然に帰る」
-
【ICF2015】伊藤穰一 - 「新メタボリズムの可能性」オープニング
Transcription
History
The company was founded by Daphne Zohar, an American entrepreneur, in 2005.[2] It was the subject of an initial public offering on the London Stock Exchange in June 2015.[3]
Operations
Companies which PureTech Health founded include Karuna Pharmaceuticals,[4] Gelesis, which has received FDA approval as a treatment for weight management,[5] Akili Interactive Labs, which is developing a digital therapeutic platform for cognitive disorders,[6] Vedanta Biosciences, which is developing drugs to treat autoimmune and inflammatory diseases,[7] and Follica which is developing new treatments for androgentic alopecia among others.[8] PureTech also has a pipeline of its own immunology, lymphatic and oncology based therapeutics.[9]
References
- ^ a b c "Annual Results 2023". PureTech Health. Retrieved 26 April 2024.
- ^ "PureTech's long view on biopharma". Boston Globe. 26 August 2015. Archived from the original on 16 August 2019. Retrieved 16 August 2019.
- ^ "PureTech banks $171M in a London IPO to fund its biotech bets". Fierce Biotech. 19 June 2015. Archived from the original on 16 August 2019. Retrieved 16 August 2019.
- ^ "PureTech Health surges as Karuna investment rockets 442%". Proactive Investors. 19 November 2019. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
- ^ "Gelesis raises $12 million for pill that staves off hunger". BetaBoston.com. May 16, 2014. Archived from the original on August 3, 2014. Retrieved December 14, 2019.
- ^ "Akili Interactive adds $13 million to Series C funding pool". The Pharma Letter. 9 August 2018. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
- ^ "PureTech Health affiliate Vedanta Biosciences awarded $5.8m grant". Sharecast. 5 December 2019. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
- ^ "Positive Results From PureTech Affiliate Male Pattern Hair Loss Study". Morning Star. 13 June 2019. Archived from the original on 1 March 2020. Retrieved 14 December 2019.
- ^ "PureTech Licenses Glyph Lymphatic Technology". FT. 29 August 2017. Archived from the original on 15 January 2020. Retrieved 14 December 2019.
External links
This page was last edited on 26 April 2024, at 22:04